Calculation
Total asset turnover | = | Revenues1 | ÷ | Total assets1 | |
---|---|---|---|---|---|
Dec 31, 2023 | 0.43 | = | 9,869,200) | ÷ | 22,730,200) |
Dec 31, 2022 | 0.49 | = | 8,930,700) | ÷ | 18,150,900) |
Dec 31, 2021 | 0.56 | = | 7,574,400) | ÷ | 13,432,500) |
Dec 31, 2020 | 0.53 | = | 6,205,683) | ÷ | 11,751,808) |
Dec 31, 2019 | 0.50 | = | 4,162,821) | ÷ | 8,318,465) |
Dec 31, 2018 | 0.49 | = | 3,047,597) | ÷ | 6,245,898) |
Dec 31, 2017 | 0.70 | = | 2,488,652) | ÷ | 3,546,014) |
Dec 31, 2016 | 0.59 | = | 1,702,177) | ÷ | 2,896,787) |
Dec 31, 2015 | 0.41 | = | 1,032,336) | ÷ | 2,498,875) |
Dec 31, 2014 | 0.25 | = | 580,415) | ÷ | 2,334,679) |
Dec 31, 2013 | 0.52 | = | 1,211,975) | ÷ | 2,319,041) |
Dec 31, 2012 | 0.55 | = | 1,527,042) | ÷ | 2,759,288) |
Dec 31, 2011 | 0.64 | = | 1,410,626) | ÷ | 2,204,280) |
Dec 31, 2010 | 0.08 | = | 143,370) | ÷ | 1,725,446) |
Dec 31, 2009 | 0.05 | = | 101,889) | ÷ | 1,955,488) |
Dec 31, 2008 | 0.18 | = | 175,504) | ÷ | 980,479) |
Dec 31, 2007 | 0.33 | = | 199,012) | ÷ | 601,477) |
Dec 31, 2006 | 0.23 | = | 216,356) | ÷ | 921,579) |
Dec 31, 2005 | 0.29 | = | 160,890) | ÷ | 548,998) |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1 US$ in thousands
Comparison to Competitors
Vertex Pharmaceuticals Inc. | AbbVie Inc. | Amgen Inc. | Bristol-Myers Squibb Co. | Danaher Corp. | Eli Lilly & Co. | Gilead Sciences Inc. | Johnson & Johnson | Merck & Co. Inc. | Moderna Inc. | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | Thermo Fisher Scientific Inc. | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec 31, 2023 | 0.43 | 0.40 | 0.28 | 0.47 | 0.28 | 0.53 | 0.43 | 0.51 | 0.56 | 0.36 | 0.26 | 0.40 | 0.43 |
Dec 31, 2022 | 0.49 | 0.42 | 0.38 | 0.48 | 0.37 | 0.58 | 0.43 | 0.51 | 0.54 | 0.71 | 0.51 | 0.42 | 0.46 |
Dec 31, 2021 | 0.56 | 0.38 | 0.40 | 0.42 | 0.35 | 0.58 | 0.40 | 0.52 | 0.46 | 0.72 | 0.45 | 0.63 | 0.41 |
Dec 31, 2020 | 0.53 | 0.30 | 0.39 | 0.36 | 0.29 | 0.53 | 0.36 | 0.47 | 0.52 | 0.03 | 0.27 | 0.50 | 0.47 |
Dec 31, 2019 | 0.50 | 0.37 | 0.37 | 0.20 | 0.29 | 0.57 | 0.36 | 0.52 | 0.55 | 0.00 | 0.31 | 0.53 | 0.44 |
Dec 31, 2018 | 0.49 | 0.55 | 0.34 | 0.64 | 0.42 | 0.56 | 0.34 | 0.53 | 0.51 | 0.00 | 0.34 | 0.57 | 0.43 |
Dec 31, 2017 | 0.70 | 0.40 | 0.27 | 0.62 | 0.39 | 0.51 | 0.37 | 0.49 | 0.46 | — | 0.31 | 0.67 | 0.37 |
Dec 31, 2016 | 0.59 | 0.39 | 0.28 | 0.58 | 0.37 | 0.55 | 0.53 | 0.51 | 0.42 | — | 0.31 | 0.70 | 0.40 |
Dec 31, 2015 | 0.41 | 0.43 | 0.29 | 0.52 | 0.43 | 0.56 | 0.62 | 0.53 | 0.39 | — | 0.29 | 0.73 | 0.41 |
Dec 31, 2014 | 0.25 | 0.72 | 0.28 | 0.47 | 0.54 | 0.53 | 0.71 | 0.57 | 0.43 | — | 0.29 | 0.73 | 0.39 |
Dec 31, 2013 | 0.52 | 0.64 | 0.28 | 0.42 | 0.55 | 0.66 | 0.48 | 0.54 | 0.42 | — | 0.30 | 0.71 | 0.41 |
Dec 31, 2012 | 0.55 | 0.68 | 0.31 | 0.49 | 0.55 | 0.66 | 0.44 | 0.55 | 0.45 | — | 0.32 | 0.66 | 0.46 |
Dec 31, 2011 | 0.64 | — | 0.31 | 0.64 | 0.54 | 0.72 | 0.47 | 0.57 | 0.46 | — | 0.36 | 0.34 | 0.44 |
Dec 31, 2010 | 0.08 | — | 0.34 | 0.63 | 0.59 | 0.74 | 0.64 | 0.60 | 0.43 | — | 0.35 | 0.42 | 0.51 |
Dec 31, 2009 | 0.05 | — | 0.36 | 0.61 | 0.57 | 0.80 | 0.67 | 0.65 | 0.24 | — | 0.23 | 0.51 | 0.47 |
Dec 31, 2008 | 0.18 | — | 0.40 | 0.70 | 0.73 | 0.70 | 0.72 | 0.75 | 0.51 | — | 0.43 | 0.36 | 0.50 |
Dec 31, 2007 | 0.33 | — | 0.41 | 0.74 | 0.63 | 0.70 | 0.64 | 0.75 | 0.50 | — | 0.42 | 0.13 | 0.46 |
Dec 31, 2006 | 0.23 | — | 0.41 | 0.70 | 0.75 | 0.71 | 0.63 | 0.76 | 0.51 | — | 0.42 | 0.11 | 0.18 |
Dec 31, 2005 | 0.29 | — | 0.41 | 0.68 | 0.87 | 0.60 | 0.48 | 0.87 | 0.49 | — | 0.44 | 0.16 | 0.62 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Sector (Pharmaceuticals, Biotechnology & Life Sciences)
Vertex Pharmaceuticals Inc., total asset turnover, long-term trends, comparison to sector (pharmaceuticals, biotechnology & life sciences)
Vertex Pharmaceuticals Inc. | Pharmaceuticals, Biotechnology & Life Sciences | |
---|---|---|
Dec 31, 2023 | 0.43 | 0.40 |
Dec 31, 2022 | 0.49 | 0.48 |
Dec 31, 2021 | 0.56 | 0.45 |
Dec 31, 2020 | 0.53 | 0.38 |
Dec 31, 2019 | 0.50 | 0.39 |
Dec 31, 2018 | 0.49 | 0.45 |
Dec 31, 2017 | 0.70 | 0.40 |
Dec 31, 2016 | 0.59 | 0.41 |
Dec 31, 2015 | 0.41 | 0.42 |
Dec 31, 2014 | 0.25 | 0.45 |
Dec 31, 2013 | 0.52 | 0.43 |
Dec 31, 2012 | 0.55 | 0.45 |
Dec 31, 2011 | 0.64 | 0.46 |
Dec 31, 2010 | 0.08 | 0.47 |
Dec 31, 2009 | 0.05 | 0.39 |
Dec 31, 2008 | 0.18 | 0.57 |
Dec 31, 2007 | 0.33 | 0.56 |
Dec 31, 2006 | 0.23 | 0.54 |
Dec 31, 2005 | 0.29 | 0.57 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Industry (Health Care)
Vertex Pharmaceuticals Inc., total asset turnover, long-term trends, comparison to industry (health care)
Vertex Pharmaceuticals Inc. | Health Care | |
---|---|---|
Dec 31, 2023 | 0.43 | 0.80 |
Dec 31, 2022 | 0.49 | 0.81 |
Dec 31, 2021 | 0.56 | 0.76 |
Dec 31, 2020 | 0.53 | 0.70 |
Dec 31, 2019 | 0.50 | 0.71 |
Dec 31, 2018 | 0.49 | 0.67 |
Dec 31, 2017 | 0.70 | 0.68 |
Dec 31, 2016 | 0.59 | 0.70 |
Dec 31, 2015 | 0.41 | 0.67 |
Dec 31, 2014 | 0.25 | 0.72 |
Dec 31, 2013 | 0.52 | 0.69 |
Dec 31, 2012 | 0.55 | 0.69 |
Dec 31, 2011 | 0.64 | 0.70 |
Dec 31, 2010 | 0.08 | 0.69 |
Dec 31, 2009 | 0.05 | 0.64 |
Dec 31, 2008 | 0.18 | 0.81 |
Dec 31, 2007 | 0.33 | 0.77 |
Dec 31, 2006 | 0.23 | 0.74 |
Dec 31, 2005 | 0.29 | 0.70 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).